Emiko Asakawa

507 total citations
18 papers, 392 citations indexed

About

Emiko Asakawa is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, Emiko Asakawa has authored 18 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Plant Science. Recurrent topics in Emiko Asakawa's work include Carcinogens and Genotoxicity Assessment (10 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Synthesis and bioactivity of alkaloids (2 papers). Emiko Asakawa is often cited by papers focused on Carcinogens and Genotoxicity Assessment (10 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Synthesis and bioactivity of alkaloids (2 papers). Emiko Asakawa collaborates with scholars based in Japan. Emiko Asakawa's co-authors include Tomoyuki Shirai, Masao Hirose, Shoji Fukushima, Hikaru Tanaka, Nobuyuki Ito, Akihiro Hagiwara, Masaaki Shibata, Shoji Fukushima, Satoru Takahashi and Hikaru Tanaka and has published in prestigious journals such as International Journal of Cancer, Carcinogenesis and Toxicologic Pathology.

In The Last Decade

Emiko Asakawa

18 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emiko Asakawa Japan 11 188 133 74 60 40 18 392
Etsuo Ikawa Japan 11 170 0.9× 143 1.1× 67 0.9× 55 0.9× 19 0.5× 18 447
Shoji Fukushima Japan 11 166 0.9× 99 0.7× 50 0.7× 57 0.9× 72 1.8× 15 354
Nobuyuki Ito Japan 11 201 1.1× 197 1.5× 25 0.3× 103 1.7× 50 1.3× 16 458
Wieslawa Kosinska United States 12 244 1.3× 125 0.9× 43 0.6× 53 0.9× 26 0.7× 21 444
Margherita Ferro Italy 13 265 1.4× 118 0.9× 28 0.4× 38 0.6× 39 1.0× 28 528
Leta Barnes United States 6 215 1.1× 101 0.8× 37 0.5× 170 2.8× 40 1.0× 13 637
Nobuyuki Ito Japan 11 178 0.9× 177 1.3× 15 0.2× 62 1.0× 50 1.3× 14 423
K. Kolanjiappan India 8 240 1.3× 68 0.5× 38 0.5× 22 0.4× 62 1.6× 8 536
Kazushi Okazaki Japan 12 138 0.7× 83 0.6× 23 0.3× 132 2.2× 58 1.4× 24 498
Tomio Ichikawa Japan 13 197 1.0× 99 0.7× 31 0.4× 19 0.3× 32 0.8× 36 447

Countries citing papers authored by Emiko Asakawa

Since Specialization
Citations

This map shows the geographic impact of Emiko Asakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiko Asakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiko Asakawa more than expected).

Fields of papers citing papers by Emiko Asakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emiko Asakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiko Asakawa. The network helps show where Emiko Asakawa may publish in the future.

Co-authorship network of co-authors of Emiko Asakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Emiko Asakawa. A scholar is included among the top collaborators of Emiko Asakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emiko Asakawa. Emiko Asakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ito, Nobuyasu, et al.. (1995). Enhancement of rat liver cell foci development by combined treatment with heterocyclic amines at low doses.. PubMed. 23. 251–9. 3 indexed citations
2.
Asakawa, Emiko, Masao Hirose, Akihiro Hagiwara, Satoru Takahashi, & Nobuyuki Ito. (1994). Carcinogenicity of 4‐methoxyphenol and 4‐methylcatechol in F344 rats. International Journal of Cancer. 56(1). 146–152. 32 indexed citations
3.
Tamano, Seiko, Hikaru Tanaka, Emiko Asakawa, et al.. (1993). No enhancing effects of calcium/magnesium salts of L‐glutamate and L‐ascorbate on tumor development in a rat medium‐term multiorgan carcinogenesis bioassay. Journal of Toxicology and Environmental Health. 39(1). 43–58. 3 indexed citations
4.
Shibata, Masa‐Aki, Tomoyuki Shirai, Emiko Asakawa, Masao Hirose, & Shoji Fukushima. (1993). Inhibition by dehydroepiandrosterone of butylated hydroxyanisole (BHA) promotion of rat‐bladder carcinogenesis and enhancement of BHA‐induced forestomach hyperplasia. International Journal of Cancer. 53(5). 819–823. 8 indexed citations
5.
Fukushima, Shoji, et al.. (1993). Carcinogenicity of catechol in F344 rats and B6C3F1 mice. Carcinogenesis. 14(3). 525–529. 38 indexed citations
6.
Tamano, Seiko, et al.. (1993). Lack of promotion of N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine‐initiated urinary bladder carcinogenesis in mice by rat cancer promoters. Teratogenesis Carcinogenesis and Mutagenesis. 13(2). 89–96. 6 indexed citations
7.
Tamano, Seiko, et al.. (1992). Forestomach Neoplasm Induction in F344/DuCrj Rats and B6C3F1 Mice Exposed to Sesamol. Japanese Journal of Cancer Research. 83(12). 1279–1285. 20 indexed citations
8.
9.
Shibata, Masaaki, Shoji Fukushima, Emiko Asakawa, Masao Hirose, & Nobuyuki Ito. (1992). The Modifying Effects of Indomethacin or Ascorbic Acid on Cell Proliferation Induced by Different Types of Bladder Tumor Promoters in Rat Urinary Bladder and Forestomach Mucosal Epithelium. Japanese Journal of Cancer Research. 83(1). 31–39. 20 indexed citations
10.
Fukushima, Shoji, Hikaru Tanaka, Emiko Asakawa, et al.. (1992). Carcinogenicity of uracil, a nongenotoxic chemical, in rats and mice and its rationale.. PubMed. 52(7). 1675–80. 50 indexed citations
11.
Hagiwara, Akihiro, Emiko Asakawa, Yasushi Kurata, et al.. (1992). Dose-Dependent Renal Tubular Toxicity of Harman and Norharman in Male F344 Rats. Toxicologic Pathology. 20(2). 197–204. 9 indexed citations
12.
Shibata, Masaaki, Masao Hirose, Hikaru Tanaka, et al.. (1991). Induction of Renal Cell Tumors in Rats and Mice, and Enhancement of Hepatocellular Tumor Development in Mice after Long‐term Hydroquinone Treatment. Japanese Journal of Cancer Research. 82(11). 1211–1219. 59 indexed citations
13.
Shibata, Masa‐Aki, Mayumi Yamada, Masao Hirose, et al.. (1990). Early proliferative responses of forestomach and glandular stomach of rats treated with five different phenolic antioxidants. Carcinogenesis. 11(3). 425–429. 15 indexed citations
14.
Hagiwara, Akihiro, Seiko Tamano, Tadashi Ogiso, Emiko Asakawa, & Shoji Fukushima. (1990). Promoting Effect of the Peroxisome Proliferator, Clofibrate, but Not Di(2‐ethylhexyl)phthalate, on Urinary Bladder Carcinogenesis in F344 Rats Initiated by N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine. Japanese Journal of Cancer Research. 81(12). 1232–1238. 14 indexed citations
15.
Fukushima, Shoji, Tomoyuki Shirai, Ryohei Hasegawa, et al.. (1990). Stomach Carcinogenicity of Caffeic Acid, Sesamol and Catechol in Rats and Mice. Japanese Journal of Cancer Research. 81(3). 207–212. 56 indexed citations
16.
Shibata, Masa‐Aki, Mayumi Yamada, Emiko Asakawa, Akihiro Hagiwara, & Shoji Fukushima. (1989). Responses of rat urine and urothelium to bladder tumor promoters: possible roles of prostaglandin E2 and ascorbic acid synthesis in bladder carcinogenesis. Carcinogenesis. 10(9). 1651–1656. 33 indexed citations
17.
Tatematsu, Masae, Tsutomu Katsuyama, Mamoru Mutai, Emiko Asakawa, & Nobuyuki Ito. (1989). Pyloric gland phenotypic expression of gastric cancers developing in the rat fundic glandular stomach. Carcinogenesis. 10(6). 1033–1039. 17 indexed citations
18.
Hirose, Masao, Tomoyuki Shirai, Yasushi Kurata, Shuji Yamaguchi, & Emiko Asakawa. (1988). EFFECTS OF NEPHROTOXIC COMPOUNDS ON RENAL- AND HEPATO-CARCINOGENESIS OF RATS. Journal of Toxicologic Pathology. 1(2). 193–198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026